A Study of CRD3874-SI in People With Leukemia

Clinical trial NCT07661095 · RECRUITING

Trial details

NCT number: NCT07661095
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia AML Refractory Acute Myeloid Leukemia

Start date: 2026-06-15
Primary completion: 2028-06-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.